American Capital Advisory, LLC Roivant Sciences Ltd. Transaction History
American Capital Advisory, LLC
- $185 Billion
- Q1 2025
A detailed history of American Capital Advisory, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, American Capital Advisory, LLC holds 19 shares of ROIV stock, worth $220. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19Holding current value
$220% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
496MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$763 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$717 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$534 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$473 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$417 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.17B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...